233 related articles for article (PubMed ID: 28400768)
1. The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against
Joffe LS; Schneider R; Lopes W; Azevedo R; Staats CC; Kmetzsch L; Schrank A; Del Poeta M; Vainstein MH; Rodrigues ML
Front Microbiol; 2017; 8():535. PubMed ID: 28400768
[No Abstract] [Full Text] [Related]
2. Fenbendazole Controls
de Oliveira HC; Joffe LS; Simon KS; Castelli RF; Reis FCG; Bryan AM; Borges BS; Medeiros LCS; Bocca AL; Del Poeta M; Rodrigues ML
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253211
[TBL] [Abstract][Full Text] [Related]
3. Antifungal and antibiofilm effect of duloxetine hydrochloride against Cryptococcus neoformans and Cryptococcus gattii.
Rehem AR; da Gama Viveiro LR; De Souza Santos EL; do Carmo PHF; da Silva NS; Junqueira JC; Scorzoni L
Folia Microbiol (Praha); 2024 Apr; ():. PubMed ID: 38652436
[TBL] [Abstract][Full Text] [Related]
4. Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease.
Nixon GL; McEntee L; Johnson A; Farrington N; Whalley S; Livermore J; Natal C; Washbourn G; Bibby J; Berry N; Lestner J; Truong M; Owen A; Lalloo D; Charles I; Hope W
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29311092
[TBL] [Abstract][Full Text] [Related]
5. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
[TBL] [Abstract][Full Text] [Related]
6. Anthraquinones against
Araújo GDS; Brilhante RSN; Rocha MGD; Aguiar L; Castelo-Branco DSCM; Guedes GMM; Sidrim JJC; Pereira Neto WA; Rocha MFG
J Med Microbiol; 2024 Mar; 73(3):. PubMed ID: 38530134
[No Abstract] [Full Text] [Related]
7. Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo.
Butts A; Koselny K; Chabrier-Roselló Y; Semighini CP; Brown JC; Wang X; Annadurai S; DiDone L; Tabroff J; Childers WE; Abou-Gharbia M; Wellington M; Cardenas ME; Madhani HD; Heitman J; Krysan DJ
mBio; 2014 Feb; 5(1):e00765-13. PubMed ID: 24520056
[TBL] [Abstract][Full Text] [Related]
8. Antifungal Activity, Antibiofilm and Association Studies with O-Alkylamidoximes against Cryptococcus spp.
de Castro Teixeira AP; Fernandes Queiroga Moraes G; de Oliveira RJ; Silva Santos C; Alves Caiana RR; Rufino de Freitas JC; Vasconcelos U; de Oliveira Pereira F; Oliveira Lima I
Chem Biodivers; 2023 Mar; 20(3):e202200539. PubMed ID: 36730650
[TBL] [Abstract][Full Text] [Related]
9. An Antivirulence Approach for Preventing Cryptococcus neoformans from Crossing the Blood-Brain Barrier via Novel Natural Product Inhibitors of a Fungal Metalloprotease.
Aaron PA; Vu K; Gelli A
mBio; 2020 Jul; 11(4):. PubMed ID: 32694141
[No Abstract] [Full Text] [Related]
10. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
[TBL] [Abstract][Full Text] [Related]
11. Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii.
Silva VKA; May RC; Rodrigues ML
Med Mycol; 2020 Oct; 58(7):928-937. PubMed ID: 31915833
[TBL] [Abstract][Full Text] [Related]
12. Brilacidin, a novel antifungal agent against
Diehl C; Pinzan CF; de Castro PA; Delbaje E; García Carnero LC; Sánchez-León E; Bhalla K; Kronstad JW; Kim D-g; Doering TL; Alkhazraji S; Mishra NN; Ibrahim AS; Yoshimura M; Vega Isuhuaylas LA; Pham LTK; Yashiroda Y; Boone C; Dos Reis TF; Goldman GH
mBio; 2024 Jun; ():e0103124. PubMed ID: 38916308
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of the opportunistic fungus Cryptococcus neoformans to anthelmintic benzimidazoles.
Cruz MC; Bartlett MS; Edlind TD
Antimicrob Agents Chemother; 1994 Feb; 38(2):378-80. PubMed ID: 8192471
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 5-Nitro-6-thiocyanatopyrimidines as Inhibitors of
Donlin MJ; Lane TR; Riabova O; Lepioshkin A; Xu E; Lin J; Makarov V; Ekins S
ACS Med Chem Lett; 2021 May; 12(5):774-781. PubMed ID: 34055225
[TBL] [Abstract][Full Text] [Related]
15. Antifungal Peptide SP1 Damages Polysaccharide Capsule of Cryptococcus neoformans and Enhances Phagocytosis of Macrophages.
Liu Y; Zhang Y; Zhao X; Lu W; Zhong Y; Fu YV
Microbiol Spectr; 2023 Mar; 11(2):e0456222. PubMed ID: 36916981
[TBL] [Abstract][Full Text] [Related]
16. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.
Saijo T; Chen J; Chen SC; Rosen LB; Yi J; Sorrell TC; Bennett JE; Holland SM; Browne SK; Kwon-Chung KJ
mBio; 2014 Mar; 5(2):e00912-14. PubMed ID: 24643864
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
18. The Antimicrobial Peptide MK58911-NH
Singulani JL; Oliveira LT; Ramos MD; Fregonezi NF; Gomes PC; Galeane MC; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0090421. PubMed ID: 34516241
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
Lu R; Hollingsworth C; Qiu J; Wang A; Hughes E; Xin X; Konrath KM; Elsegeiny W; Park YD; Atakulu L; Craft JC; Tramont EC; Mannino R; Williamson PR
mBio; 2019 May; 10(3):. PubMed ID: 31138748
[No Abstract] [Full Text] [Related]
20. A Novel Protocol for the Isolation of Fungal Extracellular Vesicles Reveals the Participation of a Putative Scramblase in Polysaccharide Export and Capsule Construction in
Reis FCG; Borges BS; Jozefowicz LJ; Sena BAG; Garcia AWA; Medeiros LC; Martins ST; Honorato L; Schrank A; Vainstein MH; Kmetzsch L; Nimrichter L; Alves LR; Staats CC; Rodrigues ML
mSphere; 2019 Mar; 4(2):. PubMed ID: 30894430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
